Investment Firm
Overview
VBI Vaccinea is a biopharmaceutical company developing novel technologies that seek to expand vaccine.
Sep 15, 2022
Post Ipo Debt
Highlights
Location
Social
Participant Investors
1
Investor Name |
---|
K2 HealthVentures |
VBI Vaccines raised $100000000 on 2022-09-15 in Post-IPO Debt
VBI Vaccinea is a biopharmaceutical company developing novel technologies that seek to expand vaccine.
Company Funding History
25
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Aug 26, 2013 | Post-IPO Debt - VBI Vaccines | - | 250.0K | |
Mar 08, 2013 | Post-IPO Debt - VBI Vaccines | - | 751.1K | |
Jul 02, 2012 | Post-IPO Debt - VBI Vaccines | - | 1.2M | |
Feb 13, 2012 | Debt Financing - VBI Vaccines | - | 2.2M |
Recent Activity
There is no recent news or activity for this profile.